Vaccine Therapy for Patients With Stage III Melanoma

Status unconfirmed · Phase 3

Conditions studied: Malignant Melanoma

In brief

This is a Phase 3 study in patients with melanoma that has spread to the lymph nodes (stage III), and who have had all of their cancer surgically removed. The purpose of this study is to evaluate the ability of the CancerVax™ vaccine to prevent or slow the recurrence of melanoma.

Key facts

Study ID
NCT00052130
Run by
CancerVax Corporation
People needed
1118
Last updated by the study team
2005-06-24

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.